Zydus launches VaxiFlu vaccine for flu protection
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
First Indian company to follow global recommendations in accordance with the World Health Organisation (WHO)
Enters the high growth vitamins, minerals and supplements segment for adults, paediatrics, and animal health
As with any medicine, the MHRA will keep the safety of gepotidacin under close review
Merger is expected to streamline operations and provide unified management focus, driving efficiency and strategic alignment
With the addition of Phase II (~91 KL) in Q1 FY26, the combined capacity of the block now stands at ~200 KL
The US generic market is crucial for Indian pharma, contributing about 35% to its total revenue, around US$ 10.7 billion
The inspection, conducted from June 23 to June 25, 2025, concluded with zero Form 483 observations
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
Subscribe To Our Newsletter & Stay Updated